Tag Archives: combo

Drug-therapy combo cuts breast cancer recurrence risk by 25%, Eli Lilly announces

Eli Lilly and Company on Sunday announced positive results in the fight against breast cancer. A drug called Verzenio, also known as abemaciclib, in combination with adjuvant endocrine therapy, was said to “significantly” reduce the risk of breast cancer recurrence by 25% for those with a common subtype of breast cancer. The combo treatment also lowered the risk… Read More »

New Astellas, Seattle Genetics Padcev combo data spark $5.8B sales hopes

Astellas and Seattle Genetics impressed Wall Street last fall when their combination of Padcev and Merck’s Keytruda fought off advanced bladder cancer in previously untreated patients. Friday, the partners presented updated results that look even better. They might even be good enough to snag an expedited regulatory review, analysts say—and at least one market-watcher hiked… Read More »